MONROVIA, Calif., Aug. 9,
2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a
leading developer, manufacturer and marketer of implantable lenses
for the eye, today announced that it will participate in the
32nd Annual Canaccord Growth Conference at the
Intercontinental Hotel in Boston.
STAAR's presentation will be on Wednesday, August 15, 2012 at
10:30 a.m. Eastern
Time.
Barry G. Caldwell, President and
CEO, will review the company's recent financial results and current
business developments. Deborah
Andrews, CFO, will also be attending. STAAR will offer
a live video webcast of its presentation on the Company's website,
www.staar.com, under Investor Information. An archived replay of
the presentation will be available for 30 days, also at
www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 25 years, designs, develops, manufactures and markets
implantable lenses for the eye. All of these lenses are foldable,
which permits the surgeon to insert them through a small
incision. STAAR's lens used in refractive surgery as an
alternative to LASIK is called an Implantable Collamer® Lens or
"ICL." A lens used to replace the natural lens after cataract
surgery is called an intraocular lens or "IOL." Over 300,000
Visian ICLs have been implanted to date; to learn more about the
ICL go to: www.visianinfo.com. STAAR has approximately 300
full time employees and markets lenses in approximately 50
countries. Headquartered in Monrovia, CA, it manufactures in the following
locations: Nidau, Switzerland;
Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please
visit the Company's website at www.staar.com or call
626-303-7902.
Collamer® is the registered trademark for STAAR's proprietary
biocompatible collagen copolymer lens material.
CONTACT:
|
Investors
|
Media
|
|
EVC
Group
|
EVC
Group
|
|
Douglas
Sherk, 415-652-9100
|
Chris
Gale
|
|
Jenifer
Kirtland, 415-568-9349
|
646-201-5431
|
SOURCE STAAR Surgical Company